These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12749913)

  • 1. PyV-mT-induced parotid gland hyperplasia as detected by altered lectin reactivity is not modulated by inducible nitric oxide deficiency.
    Ellies LG
    Arch Oral Biol; 2003 Jun; 48(6):415-22. PubMed ID: 12749913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase.
    Ellies LG; Fishman M; Hardison J; Kleeman J; Maglione JE; Manner CK; Cardiff RD; MacLeod CL
    Int J Cancer; 2003 Aug; 106(1):1-7. PubMed ID: 12794750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
    Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
    Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
    Webster MA; Hutchinson JN; Rauh MJ; Muthuswamy SK; Anton M; Tortorice CG; Cardiff RD; Graham FL; Hassell JA; Muller WJ
    Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic Polyoma middle-T mice model premalignant mammary disease.
    Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL
    Cancer Res; 2001 Nov; 61(22):8298-305. PubMed ID: 11719463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.
    Maglione JE; McGoldrick ET; Young LJ; Namba R; Gregg JP; Liu L; Moghanaki D; Ellies LG; Borowsky AD; Cardiff RD; MacLeod CL
    Mol Cancer Ther; 2004 Aug; 3(8):941-53. PubMed ID: 15299077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.
    Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ
    Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
    Al Masri A; Gendler SJ
    Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
    Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
    Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The simultaneous induction of tumorigenesis and Cre-loxP recombination in mice.
    Sakahara M; Ohkawara H; Nakao K; Yokozaki H; Aiba A
    Kobe J Med Sci; 2009 Mar; 54(6):E279-89. PubMed ID: 19628969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis.
    Kisley LR; Barrett BS; Bauer AK; Dwyer-Nield LD; Barthel B; Meyer AM; Thompson DC; Malkinson AM
    Cancer Res; 2002 Dec; 62(23):6850-6. PubMed ID: 12460898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation.
    Bierie B; Nozawa M; Renou JP; Shillingford JM; Morgan F; Oka T; Taketo MM; Cardiff RD; Miyoshi K; Wagner KU; Robinson GW; Hennighausen L
    Oncogene; 2003 Jun; 22(25):3875-87. PubMed ID: 12813461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase activities in mammalian parotid and submandibular salivary glands.
    Mitsui Y; Yasuda N; Furuyama S; Sugiya H
    Arch Oral Biol; 1997 Sep; 42(9):621-4. PubMed ID: 9403115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
    Brodie SG; Xu X; Li C; Kuo A; Leder P; Deng CX
    Oncogene; 2001 Mar; 20(12):1445-54. PubMed ID: 11313888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
    Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced muscarinic parotid secretion is underlain by impaired NO signaling in diabetic rabbits.
    Roganović J; Djukić LJ; Kršljak E; Tanić N; Stojić D
    Oral Dis; 2015 Jul; 21(5):634-40. PubMed ID: 25703905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathobiology of salivary gland. II. Morphological evaluation of acinic cell carcinomas in the parotid gland of male transgenic (MMTV/v-Ha-ras) mice as a model for human tumours.
    Dardick I; Burford-Mason AP; Garlick DS; Carney WP
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(2):105-13. PubMed ID: 1325087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family members.
    Webster MA; Martin-Soudant N; Nepveu A; Cardiff RD; Muller WJ
    Oncogene; 1998 Apr; 16(15):1963-72. PubMed ID: 9591780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
    Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
    Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.